Part 2 of 4: Recruitment may bring people into sterile processing. Development is what determines whether they stay.
|Articles|June 17, 2011
No Healing in a Vacuum
Advertisement
Negative-pressure wound therapy probably does not promote healing. This is the conclusion of Frank Peinemann and Stefan Sauerland's meta-analysis in the current edition of Deutsches Ãrzteblatt International (Dtsch Arztebl Int 2011; 108[22]: 381-9).
In negative-pressure wound therapy (NPWT), wounds are covered with an airtight film and an adjustable negative pressure is applied using an electronically controlled pump. The negative pressure drains wound exudate and is thought to promote healing. This procedure is used in particular for chronic persistent wounds and complicated wounds.
The research included a total of 21 randomized controlled trials that reported on commercially available NPWT systems and systems not commercially available. The proportion of patients with complete wound closure was reported in only five trials, and only two showed a statistically significant effect in favor of NPWT. The results on complete wound closure are not homogenous, and as yet it cannot be concluded that NPWT is superior to the control treatment.
Advertisement
Related to this article
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
Behind every landmark in infection prevention, from antimicrobial stewardship guidelines to the COVID-19 town halls that reached flight attendants and teachers, is a generation of physician-scientists who led SHEA through crises, organizational change, and scientific breakthroughs. Infection Control Today traces 30 years of SHEA presidents and the lasting mark they left on the field.
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.
An infection preventionist examines the DRC’s Ebola response through contact tracing and community engagement, explaining why daily follow-up, timely investigations, and trust reveal challenges that cumulative case counts alone cannot capture.
Four vaccine experts discuss how sustained financing, local research leadership, and community trust can strengthen vaccine development in low- and middle-income countries (LMICs), drawing on practical insights from India and Bangladesh.
GeoVax CEO David Dodd discusses how vaccine storage requirements, supplier diversification, and regional manufacturing shape outbreak preparedness, with considerations for infection preventionists and health systems preparing to receive and administer doses.
Part 4 of 4: Why better planning for surgical growth, operational performance, and patient safety requires sterile processing expertise early in the decision-making process.
Advertisement
Advertisement
Trending on Infection Control Today
1
TMVII Sexually Transmitted Ringworm: Symptoms, Diagnosis, Treatment, and Prevention
2
From Stockpile to Patient: Preparing Vaccine Delivery Before an Outbreak
3
The Next Generation of SPD Leadership: From the Basement to the Boardroom
4
Vaccine Development in LMICs: Financing, Clinical Trial Capacity, and Equitable Access
5